Morbus Crohn--a disease of failing macroautophagy in the immune system?

Sonja Meixlsperger1, Christian Münz

  • 1Viral Immunobiology, Institute of Experimental Immunology, University Hospital of Zürich, Zürich, Switzerland.

International Immunology
|September 19, 2009
PubMed

Insights

Mutations in macroautophagy genes link to Crohn's disease (CD). Macroautophagy is crucial for immune system function, offering therapeutic targets for CD and potential for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cell Biology
  • Gastroenterology

Background:

  • Crohn's disease (CD) is an inflammatory bowel disease linked to genetic mutations affecting macroautophagy.
  • Macroautophagy dysfunction is increasingly recognized as a key factor in CD pathogenesis.
  • Understanding the role of macroautophagy in immunity is critical for inflammatory bowel disease research.

Purpose of the Study:

  • To elucidate the role of macroautophagy in supporting both innate and adaptive immunity.
  • To explore the implications of macroautophagy in immune system maintenance and self-non-self discrimination.
  • To identify potential therapeutic strategies for Crohn's disease and enhance anti-tumor/anti-pathogen immunity.

Main Methods:

  • Review and synthesis of existing literature on macroautophagy and immune function.
  • Analysis of genetic links between macroautophagy genes and Crohn's disease.
  • Discussion of macroautophagy's involvement in immune cell homeostasis and antigen presentation.

Main Results:

  • Macroautophagy plays a vital role in maintaining immune system components.
  • It is essential for antigen processing and presentation to the immune system.
  • Macroautophagy educates the immune system to differentiate self from non-self pathogens.

Conclusions:

  • Altered macroautophagy is a significant factor in Crohn's disease development.
  • Targeting macroautophagy pathways offers promising therapeutic avenues for CD.
  • Harnessing macroautophagy mechanisms could lead to improved immune responses against infections and cancer.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...